This sction contains some top-level prescribing information comparing NHS Boards. The chart below highlights the cost per treated patient which has decreased by £17.00 in NHS Scotland between 2020/21 and 2022/23.


Respiratory costs per treated patient



Generic prescribing 

National and local guidance promotes branded prescribing of all inhalers excluding salbutamol inhalers. This ensures that the correct inhaler device and product is given to the individual (e.g. formulations of inhaled corticosteroids differ in potency). The chart below shows prescribing of generic inhalers across health boards, showing improvements across all boards.


Proportion of generically prescribed inhalers as a proportion of all inhalers (excluding salbutamol)


The numerical data for NTI graphs can also be viewed here.

The most up to date national therapeutic indicator data is available here.